Antimicrobial Agents and Chemotherapy

Biography

Biography: Isabel Portero Sánchez

Abstract

Chemotherapy continues to be the cornerstone treatment for cancer, though biotechnological antibodies have revolutionized this field, adding unquestionable value to traditional treatment schemes, and continue offering more advances. The latest player in the field is Advanced Therapies, which are defined by EMA and FDA as those treatments based on, or which include, “Cell Therapy” “Gene Therapy” and “Tissue Engineering”. Advanced Therapies are considered a potential new breakthrough in cancer treatment, mainly through three strategies in which they can offer an important contribution: —Oncolitic virus, that delivers powerful poisons directly to cancer cells —Manipulation of cancer cell microenvironment with Cell therapy products, in order to skip tumor immune evasion and thus helping the immune system attack cancer cells —Treatments aimed at new genes and cancer pathways, plus better tests to predict which patients will benefit from them. In this talk a revision of current achievements in Advanced Therapies for cancer will be presented.